Advertisement

Lasers in Medical Science

, Volume 22, Issue 2, pp 119–126 | Cite as

Nd:YAG lasers (1,064 nm) in the treatment of venous malformations of the face and neck: challenges and benefits

  • Kathrin SchererEmail author
  • Milton Waner
Original article

Abstract

Neodymium:yttrium aluminum garnet (Nd:YAG) laser therapy for venous malformations (VMs) of the head and neck is a rather new therapeutical option in addition to sclerotherapy and surgery. One hundred forty-six patients (age 2 months to 77.5 years) with VMs in the head/neck (localized, diffuse, and multifocal) were retrospectively analyzed with regard to number and quality of treatments and laser parameters used. Of these patients, 72 had no prior treatment of any kind, and 74 were pretreated. Laser treatment of mucosa and tongue was done with a mean fluence of 103.1 J/cm2, of skin with 90.7 J/cm2, and of glomuvenous malformations with 81.2 J/cm2. Complex VM can mostly be controlled but rarely cured. Initial Nd:YAG laser therapy is important in the treatment of VMs regarding shrinkage of the tissue, discoloration, and induction of the desired dermal fibrosis that facilitates the surgical handling of the skin and reduces the risk of skin loss in surgery and sclerotherapy.

Keywords

Venous malformation Sclerotherapy Laser therapy Nd:YAG laser Surgery 

Abbreviations

cw

Continuous wave

GVM

Glomuvenous malformation

LT

Laser therapy

MRI

Magnet resonance imaging

Nd:YAG

Neodymium:yttrium aluminum garnet

ST

Sclerotherapy

VM

Venous malformation

References

  1. 1.
    Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69:412–422PubMedCrossRefGoogle Scholar
  2. 2.
    Vikkula M, Boon LM, Mulliken JB (1998) Molecular basis of vascular anomalies. Trends Cardiovasc Med 8:281–292PubMedCrossRefGoogle Scholar
  3. 3.
    Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olson BR (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181–1190PubMedCrossRefGoogle Scholar
  4. 4.
    North PE, Mihm MC (2001) Histopathological diagnosis of infantile hemangiomas and vascular malformations. In: Vascular birthmarks of the head and neck, facial plastic surgery clinics of North America. Elsevier, Amsterdam, The Netherlands, pp 505–524Google Scholar
  5. 5.
    Yamaki T, Nozaki M, Fujiwara O, Yoshida E (2002) Duplex-guided foam sclerotherapy for the treatment of the symptomatic venous malformations of the face. Dermatol Surg 28:619–622PubMedCrossRefGoogle Scholar
  6. 6.
    Yamaki T, Nozaki M, Sasaki K (2000) Color duplex-guided sclerotherapy of the treatment of venous malformations. Dermatol Surg 26:323–328PubMedCrossRefGoogle Scholar
  7. 7.
    Pappas DJ Jr, Persky MS, Berenstein A (1998) Evaluation and treatment of head and neck venous vascular malformations. Ear Nose Throat J 77:914–922PubMedGoogle Scholar
  8. 8.
    Lee BB, Kim DI, Huh S, Kim HH, Choo IW, Byun HS, Do YS (2001) New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg 33:764–772PubMedCrossRefGoogle Scholar
  9. 9.
    Siniluoto TMJ, Svendson Pa, Wikholm GM, Fogdestam I, Edström S (1997) Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg 31:145–150PubMedGoogle Scholar
  10. 10.
    Berenguer B, Burrows PE, Zurakowski D, Mulliken JB (1999) Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 104:1–11PubMedCrossRefGoogle Scholar
  11. 11.
    Suh JS, Shin KH, Na JB, Won JY, Hahn SB (1997) Venous malformations: sclerotherapy with a mixture of ethanol and lipiodol. Cardiovasc Intervent Radiol 20:268–273PubMedCrossRefGoogle Scholar
  12. 12.
    Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH (2003) Advanced management of venous malformation with ethanol sclerotherapy: Mid-term results. Ja Vasc Surg 37:533–538CrossRefGoogle Scholar
  13. 13.
    Ohlms LA, Forsen J, Burrows PE (1996) Venous malformation of the pediatric airway. Int J Pediatr Otorhinolaryngol 37:99–114PubMedCrossRefGoogle Scholar
  14. 14.
    Pascarella L, Bergan JJ, Yamada C, Mekenas L (2005) Venous angiomata: treatment with sclerosant foam. Ann Vasc Surg 19:457–464PubMedCrossRefGoogle Scholar
  15. 15.
    Cabrera Garrido JR, Cabrera Carcia-Olmedo JR, Garcia-Olmedo Dominguez MA (1997) Elargissement des limites de la sclerotherapie: nouveaux produits sclerosants. Phlebologie 50:181–188Google Scholar
  16. 16.
    Monfreux A (1997) Traitement sclerosant des troncs sapheniens et leurs collaterales de gros calibres par la methode MUS. Phlebologie 50:351–353Google Scholar
  17. 17.
    Tessari L (2000) Nouvelle technique d’obtention de la scleromousse. Phlebologie 53:129Google Scholar
  18. 18.
    Frullini A, Cavezzi A (2002) Sclerosino foam in the treatment of varicose veins and teleangiectasias: history and analysis of safety and complications. Dermatol Surg 28:11–15PubMedCrossRefGoogle Scholar
  19. 19.
    Dern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D (2004) Single-blind randomized study comparing chromated glycernin, Polidocanol solutions, polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg 30:367–372CrossRefGoogle Scholar
  20. 20.
    Rautio R, Laranne J, Kähärä V, Saarinene J, Keski-Nisula L (2004) Long-term results and quality of life after endovascular treatment of venous malformations in the face and neck. Acta Radiol 7:738–744CrossRefGoogle Scholar
  21. 21.
    Suen JY, Waner M (1989) Treatment of oral cavity vascular malformations using the neodymium:YAG laser. Arch Orolaryngol Head Neck Surg 115:1329–1333Google Scholar
  22. 22.
    Preeyanont P, Nimsakui N (1994) The Nd:YAG laser treatment of hemangioma. J Clin Laser Med Surg 12:225–229PubMedGoogle Scholar
  23. 23.
    Landthaler M, Haina D, Brunner R (1986) Laser therapy for vascular lesions. J Am Acad Dermatol 14:107–117PubMedCrossRefGoogle Scholar
  24. 24.
    Chang CJ, Fisher DM, Chen YR (1999) Intralesional photocoagulation of vascular anomalies of the tongue. Br J Plast Surg 52:178–181PubMedCrossRefGoogle Scholar
  25. 25.
    Derby LD, Low DW (1997) Laser treatment of facial venous vascular malformations. Ann Plast Surg 38:371–378PubMedCrossRefGoogle Scholar
  26. 26.
    Wimmershoff MB, Landthaler M, Hohenleutner U (1999) Percutaneous and combined percutaneous and intralesional Nd:YAG-laser therapy for vascular malformations. Acta Derm Venereol (Stockh) 79:71–73CrossRefGoogle Scholar
  27. 27.
    Groot D, Rao J, Johnston P, Nakatsui T (2003) Algorithm for using a long-pulsed Nd:YAG laser in the treatment of deep cutaneous vascular lesions. Dermatol Surg 29:35–42PubMedCrossRefGoogle Scholar
  28. 28.
    Enjolras O (2003) Vascular malformations. In: Bolognia JL, Jorizzo JL, Rapini RP (eds) Dermatology. Elsevier, Philadelphia, p 1616Google Scholar
  29. 29.
    Manstein D, Poureshagh M, Yaroslavsky I, Altshuler G, Andersson RR (2002) Spatially confined photothermalysis of dermal targets using an IR-fiber laser in combination with focusing and contact cooling. Lasers Surg Med 30(S14):28Google Scholar
  30. 30.
    Khan MH, Kehl Sink R, Manstein D, Eimerl D, Anderson RR (2005) Intradermally focused infrared laser pulses: thermal effects at defined tissue depths. Lasers Surg Med 36:270–280PubMedCrossRefGoogle Scholar
  31. 31.
    Schmults CD, Phelps R, Goldberg DJ (2004) Nonablative facial remodeling. Arch Dermatol 140:1373–1376PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2007

Authors and Affiliations

  1. 1.The Vascular and Birthmarks Institute of New YorkRoosevelt HospitalNew YorkUSA

Personalised recommendations